🍽️ loracarbef (antibiotic)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Respiratory Tract Infections: Loracarbef is effective against bacterial infections of the respiratory tract, including acute bronchitis, community-acquired pneumonia, and bacterial sinusitis. It can help alleviate symptoms and eradicate the underlying bacterial infection.

  2. Ear Infections: Loracarbef may be prescribed for the treatment of acute otitis media (middle ear infection) caused by susceptible bacteria. It helps in reducing inflammation and resolving the infection.

  3. Skin and Soft Tissue Infections: Loracarbef can be used to treat bacterial skin infections, such as cellulitis, folliculitis, and impetigo. It works by inhibiting the growth of bacteria responsible for these infections.

  4. Urinary Tract Infections (UTIs): Loracarbef may be used to treat uncomplicated urinary tract infections caused by susceptible bacteria. It helps in eliminating the bacteria responsible for the infection from the urinary tract.

  5. Streptococcal Infections: Loracarbef is effective against infections caused by Streptococcus species, including Streptococcus pyogenes (group A streptococcus). It is sometimes used to treat streptococcal pharyngitis (strep throat) and skin infections caused by streptococci.

  6. Other Bacterial Infections: Loracarbef may also be prescribed for other bacterial infections, depending on the susceptibility of the organism. This may include infections of the gastrointestinal tract, bone and joint infections, and sexually transmitted infections.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of loracarbef (antibiotic) On Probiotics

Bacteria Impacted by loracarbef (antibiotic)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

Impact of loracarbef (antibiotic) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.
Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]

Due to AI drones slamming this site, we have added IP blocking on excessive calls. Email us if you get blocked and send this [216.73.216 ]